Impact of the Urban Zen Initiative on patients' experience of admission to an inpatient oncology floor: a mixed-methods analysis.
J Altern Complement Med., Aug;17(8):729-34 (2011)
Energy dependence of response of new high sensitivity radiochromic films for megavoltage and kilovoltage radiation energies.
Med Phys., Nov;32(11):3350-4 (2005)
Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer.
Cancer J., 12(3):182-8 (2006)
The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer.
Brachytherapy., 7(1):22-8 (2008)
Intraoperative high-dose-rate brachytherapy--a novel technique in the surgical management of axillary recurrence.
Breast J., 15(2):140-5 (2009)
Partial breast brachytherapy as the primary treatment for breast cancer diagnosed after mantle radiation therapy for Hodgkin's disease.
Am. J. Clin. Oncol., Apr;32(2):132-6 (2009)
American society for radiation oncology intersociety summit summary.
Int. J. Radiat. Oncol. Biol. Phys., Mar;76(3):643-8 (2010)
Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer.
Clin. Breast Cancer., Feb;12(1):57-62 (2012)
Cost savings in inpatient oncology through an integrative medicine approach.
Am J Manag Care., Dec;17(12):779-84 (2011)
Is there a role for postmastectomy radiation therapy in ductal carcinoma in situ?
Int J Surg Oncol., 2012:423520 (2012)
A new treatment planning formalism for catheter-based beta sources used in intravascular brachytherapy.
Cardiovasc. Radiat. Med., 2(3):157-64 (2001)
Ytterbium-169: a promising new radionuclide for intravascular brachytherapy.
Cardiovasc. Radiat. Med., 2(3):173-80 (2001)
High-dose-rate intraoperative irradiation: current status and future directions.
Semin Radiat Oncol., Jan;12(1):62-80 (2002)
Clearance assurance for stereotactic radiosurgery and radiotherapy.
Med Phys., Jan;29(1):45-50 (2002)
Brachytherapy in the treatment of head and neck cancer.
Oncology (Williston Park, N.Y.)., Oct;16(10):1379-93; discussion 1393, 1395-6 (2002)
Prevalence of anemia in cancer patients undergoing radiotherapy: prognostic significance and treatment.
Oncology., 63 Suppl 2:11-8 (2002)
Impact of tumor hypoxia and anemia on radiation therapy outcomes.
Oncologist., 7(6):492-508 (2002)
Thermoluminescent dosimetry of the SourceTech Medical model STM1251 125I seed.
Med Phys., Jul;30(7):1732-5 (2003)
Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy.
Cancer., Sep;98(5):1072-9 (2003)
Rationale for integrating high-dose rate intraoperative radiation (HDR-IORT) and postoperative external beam radiation with subcutaneous amifostine for the management of stage III/IV head and neck cancer.
Semin. Oncol., Dec;30(6 Suppl 18):40-8 (2003)